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Background. Prison populations tend to be marginalized and disadvantaged of the rights and freedoms that other people in the
community benefit from. Their separation from families, a narrow room and lack of privacy in the prison, violence between
prisoners, and the uncertainty about the future result in psychological distress, for example, depression. The review has
synthesized previous studies conducted on the topic and summarized to formulate recommendations for future prison health
care services. Methods. We systematically searched the databases: PubMed, Psych Info, and SCOPUS, as well as manual Google
Scholar searches, were conducted to retrieve published literature globally. We have included observational studies, written in
English language. Estimates were pooled using a random-effects model. The study protocol was registered in PROSPERO with
protocol number CRD42020156108. Subgroup and sensitivity analysis was conducted, and heterogeneity across the studies was
evaluated using Q and the I2-test. Publication bias was assessed by inspection of the funnel plot and Egger’s regression test.
Result. A total of 1313 studies were initially identified through the electronic database; among these, a total of 73 full-text articles
were retrieved for further appraisal. Further, 32 full-text articles were included in the final systematic review and meta-analysis.
In this meta-analysis, the pooled prevalence of depression among prisoners was 36.9% (95% CI; 27.3-47.6). The pooled
prevalence of depression among prisoners in the developing and developed countries was 39.2% and 33.1%, respectively.
Moreover, the prevalence of depression was 19.1% and 54% for the studies that used diagnostic and screen tools to diagnose or
screen depression, respectively. A leave-one-out analysis revealed that the pooled prevalence of depression among prisoners was
not dependent on a single study removal or addition. Thus, the pooled prevalence of depression ranges between 35.3 and 38.0%.
Conclusion. The prevalence of depression among prisoners was high. Therefore, regular and continuous screening of depressive
symptoms for prisoners along with its appropriate management is highly recommended.
1. Background
Depression is a major psychiatric problem mainly explained
by a feeling of depressed mood, sadness, and a loss of interest
in activities that you usually enjoy, accompanied by impair-
ment of social and occupational activities for at least two
weeks [1]. Depression has a significant contribution to the
global burden of disease and affects all communities across
the world [1, 2]. The World Health Organization mental
health survey conducted across 17 countries found that on
average, 1 in 20 people reported having an episode of depres-
sion [2].
Different studies conducted among prisoners in several
countries have shown a high prevalence of psychiatric mor-
bidity. The prevalence of severe mental disorders among
prisoners can be 5 to 10 times higher than in the general
population [3]. Depression is especially prevalent in prison
population [4]. The overall prevalence of depression among
prisoners is found to be 45.5% [5] and 56.4% [6] in Ethiopia,
19.2% [7] in Norway, 57.4% [8] in Turkey, and 72.6% [9] in
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Nigeria. Unfortunately, offenders with severe mental disor-
ders are ignored by prison officers and staff [10].
Globally, there are more than 10.2 million individuals
detained in prisons [11]. Among these, the USA has the high-
est prison population, around 2.24 million [12]. The rate of
prisoners has increased from 136 to 144 per 100,000 of the
world population, with a significant difference among the
regions. In the last 15 years, the prison population has risen
in Latin America with a higher (150%) increment in Brazil
[13, 14]. Although it varies among the countries, the prison
population has also risen in Asia, Europe, Oceania, and the
Gulf region [14]. In Africa, a 76% rise has been observed in
Algeria between 2001 and 2003 [14]. While South Africa’s
prison population rate has decreased from 394 to 328 per
100,000 of the total country’s population between 2000 and
2010 [15], Ethiopia’s prison population rate has increased
from 94 to 124 per 100,000 of the total population between
2000-2011 [13, 14, 16].
Different studies suggest that prisoners are at higher risk
of developing mental illness. This can be attributed to many
probable factors like incarceration results in loss of personal
freedoms and opportunities, such as social supports, inter-
personal relationships, employment, social status, and social
roles [9]. The condition of a prison such as a narrow room,
lack of privacy, violence between prisoners, social neglect,
lack of mental health access, and the effects of the prison sen-
tence may lead to depression [15]. In addition, risk factors of
depression among prisoners include a family history of a
condition, major life changes, chronic health problems, and
substance abuse [17].
We found a significant variation in the prevalence of
depression among prisoners across the studies conducted
globally. However, there are no previous systematic reviews
and meta-analysis conducted on the topic of interest. It is
hypothesized that a substantial proportion of prisoners
would have depression globally. Therefore, this review is
aimed at conducting a systematic review and meta-analysis
to systematically summarize the magnitude of depression
among prisoners and formulate recommendations for future
prison health care services.
2. Methods
2.1. Literature Search Strategy and Selection Process. Pre-
ferred reporting items for systematic review and meta-
analysis (PRISMA) guideline [18] were used to systematically
review the literature (see supplementary file 1). The elec-
tronic databases such as PubMed, Scopus, Psych Info, and
manual Google Scholar search were searched for relevant
articles. A search strategy was developed for each database
by using a combination of free texts and Mesh terms. Search
terms and the keyword which were used for PubMed are
((“Epidemiology” OR “Prevalence” OR “Magnitude” OR
“Incidence”) AND ((“Depression” [Mesh] OR “Depressive
Disorder” [Mesh] OR “Major depressive disorder” [Mesh]
OR “depressive symptoms” [Mesh] OR (Depression [Title/-
Abstract] ORDepressive Disorder [Title/Abstract] ORMajor
depressive disorder [Title/Abstract] OR depressive symp-
toms” [Title/Abstract])) AND ((offender [Title/Abstract]
OR inmates [Title/Abstract] OR prisoner [Title/Abstract]
OR person in custody [Title/Abstract]))). Also, we have man-
ually searched Google scholar and the reference lists of
review articles, and retrieved full-text articles were also exam-
ined for additional papers that were eligible for this review to
identify additional literatures. Search limits used in the data-
bases include studies published in English and the period
starting from October 1, 2001, to November 10, 2019. This
systematic review and meta-analysis protocol has been regis-
tered in PROSPERO (CRD42020156108).
2.2. Eligibility Criteria. Eligible studies for this review had to
fulfill the following criteria for inclusion:
(1) Studies which assessed and reported data on the
prevalence and/or magnitude of depression among
prisoners
(2) The type of studies should be observational (cross-
sectional, nested case-control, or prospective cohort
or retrospective study design).
(3) The study participants of reported studies should be
prisoners
Exclusion Criteria:
(1) Duplicate studies, reviews, clinical trials, commentar-
ies, short communications, and letters to editors
(2) Studies published other than English were excluded
from the review
2.3. Methods for Data Extraction and Quality Assessment.
Data extraction was done using specific data extraction for-
mat prepared in the Microsoft Excel spreadsheet. After delet-
ing duplicates, each investigator read titles and abstracts
closely to include all potential articles. Full-text articles were
obtained and reviewed for all criteria. We have resolved the
disagreement through discussion and consensus with the
research team.
The following information was extracted from eligible
full-text articles: author’s name, year of publication, country,
sample size, study design, the instrument used to assess
depression, sampling technique, response rate, and preva-
lence of depression. The quality of the included studies was
evaluated using a modified version of the Newcastle-Ottawa
Scale (NOS) [19].
2.4. Data Synthesis and Analysis. A Comprehensive Meta-
Analysis software (CMA) version 3 was used to conduct all
analyses. Studies were pooled to calculate pooled prevalence,
odds ratios, and 95% CI using a random-effects model [20].
The magnitude of statistical heterogeneity between studies
was assessed using I2-statistics, and values of 25, 50, and
75% were considered to represent low, medium, and high,
respectively [21]. Possible publication bias was assessed by
inspection of the funnel plot and Egger’s regression tests
[22, 23].
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3. Results
3.1. Identification of Studies. The electronic database and
additional manual search resulted in a total of 1332 research
articles. Of these, a total of 73 full-text articles were retrieved
for further appraisal after a careful and organized screening
of titles and abstracts. Finally, 32 full-text articles which ful-
filled the inclusion criteria were part of the current review
(see Figure 1).
3.2. Characteristics of Included Studies.We included a total of
32 articles employed in both developed (14 studies) and
developing (18 studies) countries representing 101,817 pris-
oners. The included research articles were published between
the year 2001 and 2019. The sample size of the included stud-
ies ranges from 24 in the UK to 82,650 in Taiwan. Among the
32 studies, four studies from the USA, three from the UK,
three from Brazil, two from Australia, two from France,
two from Chile, two from Iran, one from each of the follow-
ing countries; China, Nepal, Ireland, Norway, Taiwan, and
Turkey, and eight from countries in Africa.
Regarding the study design of the included studies, four
used a cohort study design, one used case-control, and
twenty-seven studies used a cross-sectional study design.
Depression among prisoners was assessed using a diagnostic
tool such as Composite International Diagnostic Interview
(CIDI), Mini-International Neuropsychiatric Interview
(MINI), the International Classification of Diseases, 9th ver-
sion (ICD-9), and the Diagnostic and Statistical Manual of
Mental Disorders, fourth edition (DSM-IV) in fourteen stud-
ies while a screening tool such as Depression Anxiety Stress
Scale (DASS), Patient health question-9 item (PHQ-9), Beck
Depression Inventory (BDI), General Health Questionnaire
(GHQ-12), Hospital Anxiety and Depression Scale (HADS),
Center for Epidemiologic Studies Depression scale (CESD),
and Montgomery Asberg Depression Rating Scale (MADRS)
in eighteen studies (see Table 1).
3.3. Methodological Quality of Included Studies. We have
used the modified Newcastle Ottawa Scale (NOS) [19] to
assess the methodologic quality of the studies included in
the current review. Of the 32 studies included in the analysis,
fourteen studies were of high methodologic quality
(NOS score ≥ 8), seventeen studies were of moderate metho-
dologic quality (NOS score 6-7), and two studies were low-
quality (NOS score ≤ 5) studies (see supplementary file 2).
3.4. The Prevalence of Depression among Prisoners (Meta-
analysis). In the current review, all analyses were conducted
using a Comprehensive Meta-Analysis software (CMA) ver-
sion 3 [49]. The pooled prevalence estimate of depression
among prisoners was 36.9% (95% CI; 27.3-47.6). Because of
apparent heterogeneity (I2 = 99:614%, Q = 8039:637, df =
31, p < 0:001) identified among the included studies, we
employed a random-effects model (see Figure 2).
PRISMA 2009 flow diagram
Records identified through data
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Figure 1: PRISMA flow chart of the study identification process for systematic reviews and meta-analyses, 2019.





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4 Depression Research and Treatment
3.5. Subgroup and Sensitive Analysis. We have conducted a
subgroup analysis based on the study design (cross-sectional,
cohort, and case-control), depression assessment tools used
in the study (diagnostic and screening tools), and the place
or country in which the study conducted (developed and
developing countries). The pooled prevalence of depression
among prisoners was higher in developing countries 39.2%
(95% CI 27.6-52.2) when compared to developed countries
33.1% (95% CI 23.7-44.0). The pooled prevalence of depres-
sion among prisoners was significantly higher in a study used
a case-control study design (88.0%) as compared to the
cohort (45.6%) and cross-sectional (33.9%) studies. Further,
we have used the depression assessment tool to conduct a
subgroup analysis. The pooled prevalence of depression was
significantly higher (54.0%) among the studies which used
screening tools to assess depression whereas remarkably
lower among the studies which used a diagnostic tool
(19.1%). The heterogeneity was significant for the studies
Study name Statistics for each study Event rate and 95% CI
Event Lower Upper Weight
rate limit limit p value (Random)
Lisa C. Barry et al., 2015 0.250 0.192 0.318 0.000 0.62
Chen et al., 2017 0.820 0.801 0.838 0.000 0.63
Osasona and Koleoso., 2015 0.730 0.679 0.776 0.000 0.62
Yi et al., 2017 0.120 0.109 0.132 0.000 0.63
Shrestha et al., 2017 0.350 0.307 0.396 0.000 0.63
Yener Unver et al., 2013 0.550 0.513 0.587 0.009 0.63
Beyen et al., 2017 0.440 0.402 0.478 0.002 0.63
R. Arnal et al., 2018 0.230 0.200 0.263 0.000 0.63
Bedaso et al., 2018 0.560 0.506 0.612 0.028 0.62
A. Baier et al., 2016 0.440 0.335 0.551 0.287 0.61
Danny J. O’Sullivan et al., 2018 0.380 0.291 0.478 0.017 0.61
Værøy., 2011 0.460 0.283 0.648 0.684 0.57
Shuford et al., 2018 0.830 0.768 0.878 0.000 0.61
N. Murdoch et al., 2008 0.490 0.402 0.578 0.826 0.62
Fazel et al., 2001 0.300 0.241 0.367 0.000 0.62
Hamzeloo et al., 2015 0.410 0.333 0.491 0.030 0.62
Andreoli SB et al., 2014 0.140 0.125 0.157 0.000 0.63
Milena P. Pond et al., 2011 0.190 0.158 0.227 0.000 0.62
Mundt AP et al., 2013 0.070 0.056 0.087 0.000 0.62
Holliday et al., 2016 0.730 0.679 0.776 0.000 0.62
Zakir Abdu et al., 2018 0.420 0.368 0.474 0.004 0.62
Alemayehu et al., 2019 0.460 0.412 0.509 0.109 0.63
Palmer, Connelly., 2005 0.880 0.682 0.962 0.002 0.50
Tao-Hsin Tung, 2018 0.110 0.108 0.112 0.000 0.63
Edward BH et al., 2012 0.140 0.109 0.178 0.000 0.62
Santos MM et al., 2019 0.213 0.191 0.237 0.000 0.63
Forry et al., 2019 0.440 0.392 0.489 0.017 0.63
Stephen Allnutt., 2008 0.150 0.132 0.170 0.000 0.63
Abdulmalik et al., 2014 0.210 0.173 0.253 0.000 0.62
Assadi et al., 2006 0.290 0.245 0.340 0.000 0.62
Getaneh et al., 2019 0.670 0.622 0.714 0.000 0.62
Ayhan et al., 2017 0.140 0.116 0.168 0.000 0.62
0.369 0.273 0.476 0.017
–1.00 –0.50 0.00 0.50 1.00
Based on random effect meta-analysis (I² = 99.614%; Q = 8039.637, df = 31, p <0.001)
Figure 2: Forest plot for the prevalence of depression among prisoners : a meta-analysis.










































































































































































































































































































6 Depression Research and Treatment
used both diagnostic and screening tools to assess depression,
I2 = 98:407, p < 0:0001 and I2 = 98:220, p < 0:001, respec-
tively (see Table 2).
Furthermore, we explored the source heterogeneity
through a one-leave-out sensitivity analysis. This analysis
revealed that the pooled prevalence of depression among
prisoners was not dependent on a single study removal or
addition. Thus, the pooled prevalence of depression ranges
between 35.3 and 38.0% (see Table 3).
3.6. Publication Bias. The funnel plot was symmetric, and
Egger’s regression tests showed no evidence of potential pub-
lication bias in the included studies (B = 13:87, SE = 2:67,
df = 30, p = 0:12) (see Figure 3).
4. Discussion
In this systematic review and meta-analysis, we explored the
prevalence of depression among prisoners. Twenty-seven
cross-sectional, four cohort studies, and one nested case-
control studies were included in the final meta-analysis.
Based on the meta-analysis result, 4 out of 10 prisoners had
depression. This implies that depression is a major public
health problem among prisoners globally.
In the current study, the overall pooled prevalence esti-
mate of depression among prisoners was 36.9% (95% CI;
27.3-47.6). In our subgroup analysis, the pooled prevalence
of depression among prisoners was 39.2% (95% CI 27.6-
52.2) in the developing countries and 33.1% (95% CI 23.7-
44.0) in developed countries. The reason for this difference
might be due to socioeconomic and cultural variations
between countries and, also, the utilization of different diag-
nostic and screening tools for assessing depression, variation
in sample size and the difference in the study period.
The result of this meta-analysis was higher than a study
conducted on 89037 people from 18 countries concluded that
the average lifetime and 12-month prevalence estimates of
major depression among the general population were 14.6%
and 5.5% in developed countries, whereas 11.1% and 5.9%
in developing countries, respectively [52]. Also, the pooled
prevalence of depression among developed and developing
countries was higher than a study conducted on a commu-
nity from 30 countries between 1994 and 2014 which
revealed a one-year and lifetime prevalence of depression
7.2% and 10.8%, respectively [53]. The possible justification
for high prevalence of depression among prisoner might be
because of the environment in prison lacks access to social
support, poor condition (narrow room, lacks privacy), occur-
rence of violence between prisoners, limited interpersonal
relationship, limited social roles, and lack of mental health
access result them in stressful life which might gradually lead
them to develop depression [9].
A subgroup analysis of the current review showed the
variation in the rates of prevalence of depression among pris-
oners as the country’s economic development differed. The
pooled prevalence of depression among prisoners was signif-
icantly higher in developing countries (39.2%) when com-
pared to developed countries (33.1%). The possible reason
for this variation might be due to economical variation which
might lead to a difference in accessing mental health service
at the prison level. This finding may be explained by the fact
that most of the inmates in a developing country were of low
socioeconomic status and may be challenged in accessing
health services by themselves [2].
We have also conducted a subgroup analysis using the
methodologic design of the studies used as a moderator.
The pooled prevalence of depression among prisoners was
significantly higher in a study used a nested case-control
study design (88.0%) as compared to the cohort (45.6%)
and cross-sectional (33.9%) studies. The possible explana-
tions may be we have got only one case-control study, which
might overestimate the prevalence when compared with the
pooled prevalence of 27 cross-sectional studies. Also, some
of the subjects might be deliberately chosen because they
Table 3: One-leave-out sensitivity analysis of the prevalence of
depression among prisoners for each study being removed at a
time (prevalence and 95% confidence).
Study excluded Prevalence (%) 95% CI
Lisa C. Barry et al., 2017 [24] 37.3 27.5-48.3
Chen et al., 2017 [25] 35.2 27.0-44.3
Osasona and Koleoso, 2015 [9] 35.7 26.4-46.3
Yi et al., 2017 [26] 38.0 27.7-49.6
Shrestha et al., 2017 [27] 36.9 27.2-47.9
Yener Unver et al., 2013 [8] 36.3 26.8-47.0
Beyen et al., 2017 [28] 36.7 27.0-47.5
Arnal R., et al., 2018 [29] 37.4 27.5-48.5
Bedaso et al., 2018 [6] 36.3 26.7-47.0
Baier A., et al., 2016 [30] 36.7 27.0-47.5
Danny J. O’Sullivan et al., 2018 [31] 36.8 27.1-47.7
Værøy, 2011 [7] 36.6 27.0-47.5
Sheford et al., 2018 [32] 35.3 27.1-47.7
Murdoch N., et al., 2008 [33] 36.5 27.0-47.5
Fazel et al., 2001 [34] 37.1 26.0-45.9
Hamzeloo et al., 2016 [35] 36.7 26.9-47.4
Andreoli SB et al., 2014 [36] 37.9 27.3-48.1
Milena P. Pond et al., 2011 [37] 37.6 27.7-48.6
Mundt AP et al., 2013 [38] 38.4 28.5-49.5
Holliday et al., 2016 [39] 35.7 26.4-46.3
Zakir Abdu et al., 2018 [40] 36.6 26.9-47.5
Alemayehu et al., 2019 [5] 36.7 27.0-47.6
Palmer, Connelly, 2005 [41] 35.3 25.9-46.1
Tao-Hsin Tung, 2019 [50] 38.0 28.8-48.2
Edward BH et al., 2012 [42] 37.8 27.9-48.9
Santos MM et al., 2019 [43] 37.5 27.4-48.7
Forry et al., 2019 [44] 36.7 27.0-47.5
Stephen Allnutt, 2008 [45] 37.8 27.7-49.1
Abdul Malik et al., 2006 [46] 37.5 27.6-48.5
Assadi et al., 2006 [51] 37.2 27.3-48.1
Getaneh et al., 2019 [47] 35.9 26.5-46.5
Ayhan et al., 2017 [48] 37.9 27.9-49.0
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have the disease in case-control studies (i.e., that is a higher
percentage of cases per study).
We have used the depression assessment tool to conduct
a subgroup analysis. The pooled prevalence of depression
was significantly higher (54.0%) in the studies using screen-
ing tools to assess depression whereas remarkably lower in
the studies using a diagnostic tool (19.1%). The possible
explanation for the remarkable difference might be due to
the variation in measuring instrument (screening and diag-
nostic) and might be due to difference in the test’s ability to
correctly identify a participant with the disease as positive
and the test’s ability to correctly label a participant without
the disease as negative [54].
4.1. Limitations. The following are limitations of our review
which needs to be considered when interpreting our find-
ings. First, only studies published in the past ten years
were part of the current review. Second, inclusion of arti-
cles only published in English could be another limitation.
However, the strength of this study includes screening of
articles was conducted by two independent investigators
to minimize the possible reviewer bias, and we also con-
ducted a subgroup, and one-leave-out sensitivity analysis
to further know source of heterogeneity among the
included studies.
5. Conclusion
In our meta-analysis, the pooled prevalence of depression
among prisoners was high (36.9%). The pooled prevalence
of depression was 54.0% and 19.1% among studies which
used screening and diagnostic tool, respectively. Attention
needs to be given for the mental health of the prisoners,
and work should be done to consider the possible integra-
tion of mental health services with the existing health care
at the prison level. Finally, future studies need to be con-
ducted using a validated instrument to be used in the
prison community and to better assess determinants of
depression among prisoners as well.
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